Ann: Webcast to discuss data presented at ESMO Plenary Session, page-3

  1. 8,753 Posts.
    lightbulb Created with Sketch. 95
    Outstanding results...........there is no reason why an oncologist would choose mono keytruda or Keytruda+chemo over Ketytruda+Efti .

    This combo has all the benefits of Keytruda alone plus an almost 7 times ORR of mono keytruda an an improved rate over Keytruda+ chemo

    FDA hopefully will approve this combo and not ask for yet another expanded trial.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
27.5¢
Change
-0.005(1.79%)
Mkt cap ! $403.6M
Open High Low Value Volume
28.0¢ 28.3¢ 27.0¢ $334.9K 1.206M

Buyers (Bids)

No. Vol. Price($)
19 572821 27.0¢
 

Sellers (Offers)

Price($) Vol. No.
27.5¢ 144039 22
View Market Depth
Last trade - 11.57am 08/08/2025 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.